Purification, Characterization, and Subunit Structure of Rat Core 1 Beta1,3-galactosyltransferase
Overview
Affiliations
The O-linked oligosaccharides (O-glycans) in mammalian glycoproteins are classified according to their core structures. Among the most common is the core 1 disaccharide structure consisting of Galbeta1-->3GalNAcalpha1-->Ser/Thr, which is also the precursor for many extended O-glycan structures. The key enzyme for biosynthesis of core 1 O-glycan from the precursor GalNAc-alpha-Ser/Thr is UDP-Gal:GalNAc-alpha-Ser/Thr beta3-galactosyltransferase (core1 beta3-Gal-T). Core 1 beta3-Gal-T activity, which requires Mn2+, was solubilized from rat liver membranes and purified 71,034-fold to apparent homogeneity (>90% purity) in 5.7% yield by ion exchange chromatography on SP-Sepharose, affinity chromatography on immobilized asialo-bovine submaxillary mucin, and gel filtration chromatography on Superose 12. The purified enzyme is free of contaminating glycosyltransferases. Two peaks of core 1 beta3-Gal-T activity were identified in the final step on Superose 12. One peak of activity contained protein bands on non-reducing SDS-PAGE of approximately 84- and approximately 86-kDa disulfide-linked dimers, whereas the second peak of activity contained monomers of approximately 43 kDa. Reducing SDS-PAGE of these proteins gave approximately 42- and approximately 43-kDa monomers. Both the 84/86-kDa dimers and the 42/43-kDa monomers have the same novel N-terminal sequence. The purified enzyme, which is remarkably stable, has an apparent Km for UDP-Gal of 630 microm and an apparent Vmax of 206 micromol/mg/h protein using GalNAcalpha1-O-phenyl as the acceptor. The reaction product was generated using asialo-bovine submaxillary mucin as an acceptor; treatment with O-glycosidase generated the expected disaccharide Galbeta1-->3GalNAc. These studies demonstrate that activity of the core 1 beta1,3-Gal-T from rat liver is contained within a single, novel, disulfide-bonded, dimeric enzyme.
Chen Y, Ji Y, Shen L, Li Y, Ren Y, Shi H J Cancer Res Clin Oncol. 2024; 150(4):214.
PMID: 38662050 PMC: 11045595. DOI: 10.1007/s00432-024-05745-y.
Zemkollari M, Oostenbrink C, Grabherr R, Staudacher E Glycobiology. 2024; 34(4).
PMID: 38366999 PMC: 11005171. DOI: 10.1093/glycob/cwae013.
Sheikh S, Lo B, Kaune H, Bansal J, Deleva A, Williams S Front Cell Dev Biol. 2023; 11:1202411.
PMID: 37614224 PMC: 10443433. DOI: 10.3389/fcell.2023.1202411.
Zemkollari M, Blaukopf M, Grabherr R, Staudacher E Molecules. 2023; 28(2).
PMID: 36677618 PMC: 9865085. DOI: 10.3390/molecules28020552.
A Sweet Warning: Mucin-Type O-Glycans in Cancer.
Zhang Y, Sun L, Lei C, Li W, Han J, Zhang J Cells. 2022; 11(22).
PMID: 36429094 PMC: 9688771. DOI: 10.3390/cells11223666.